Displaying items by tag: women
If you are interested in seeing if you may qualify for an ongoing clinical study, please contact Christina Ndolo at cmndolo@uabmc.edu.
About the Clinical Trial:
The purpose of this NIH funded trial is to examine the effects of three different diabetes treatments to determine if they improve night-time blood sugars.
This Trial Involves:
- A screening visit that includes a blood draw, urine test and physical exam
- Treatment with Metformin, Insulin Glargine (long-acting insulin) or the experimental drug Dorzagliatin which is FDA-approved for research, for up to 8 weeks
- 2-4 inpatient visits/ including two overnight stays at the Clinical Research Unit at 15th floor of Jefferson Tower.
All visits to be completed within a three-month period. Study-related tests and procedures are provided free of charge. Participants will be compensated up to $2,500 for study completion. All Participants must be Diagnosed with type 2 DM and Not on any type of insulin therapy.
Please contact Kathryn Hollifield-Laumer at khollifield@uabmc.edu or co-investigators Chanel Mason at 205-934-1921 or cnmason@uabmc.edu, or Alaaeldin Hodhod at ahodhod@uabmc.edu.
If you experience urine leakage and you are 65 years or older, you may qualify for the study.
We are assessing whether hip exercises can improve pelvic floor muscle strength and urinary leakage.
You will serve as a “control.” At the visit, you will undergo a routine examination (10 minutes) for urinary leakage and answer questionnaires (10-15 minutes).
You will come to clinic for two visits.
$100 ($50 at each visit) compensation will be provided.
For more information, please call 205.934.5498.
- Are you 18-60 years of age living with HIV, and want to be a part of a vaccine study?
- Is your viral load suppressed/undetectable?
- Are you able to receive a vaccine?
- Are you generally healthy?
- Are you willing to temporarily stop taking antiretrovirals?
You may qualify for a study looking at testing an experimental HIV vaccine with an experimental adjuvant to see how the immune responses change among participants who do an antiretroviral analytical treatment interruption (ATI) compared to those who do not. Compensation at each study visit will be provided for time and travel. Transportation services are also available upon request. If interested, please email sspaulding@uabmc.edu.
Participants will be compensated a total of $200. Only requires 2 visits.
For information, call us at 205-934-5498 or email: urogynecology@uabmc.edu
• A woman on parole, probation, or recently released from prison or jail?
• A woman who has used drugs?
• Interested in learning about a way to protect yourself against HIV?
You may qualify for a paid research study at the University of Alabama at Birmingham, in partnership with Yale University.
• Participate in confidential study interviews at our research office.
• Earn $50 for each interview, up to $225 for participating in the study.
Fill out our contact survey at: https://yalesurvey.ca1.qualtrics.com/jfe/form/SV_d7sAjr6GDsjiJng?Q_CHL=qr
Or you may call: (205) 934-2851 or Email: AthenaStudy@uabmc.edu
Questionnaires, interviews, and biological measures of smoking will be used to assess the treatment's effects on mood and smoking. Participants will be compensated $50 per session. If you would like to discuss the possibility of volunteering, please call 205-996-1198, or go to www.quitsmokingbaltimore.org for more information about the study and to complete the online study prescreener for the UAB site. Confidentiality will be maintained for all applicants and participants.
Volunteers must be 21 years of age or older, and must live within travel distance of the study site in Birmingham.
To qualify patients need to be 18-75 years of age, failed to respond to an adequate dose & duration of at least 2 medicines for depression. If currently taking antidepressants, willing and able to discontinue.
If eligible, study participants will be expected to abstain from illicit drugs for the duration of the trial & attend all study visits & follow instructions from the study doctor. Study examinations will be at no cost to you.
For more information please contact 205-996-1198 or spremani@uab.edu
This study will compare the effectiveness of two different treatments for urge urinary incontinence (UUI). One treatment is Botox injections in the bladder, and the other is an oral medication (mirabegron or vibegron).
Participants compensated up to $425.
For more information about this study, please email or at urogynecology@uabmc.edu or 205-934-5498.
We are looking for people with knee osteoarthritis to participate in a study to examine whether a diet intervention can reduce pain and improve quality of life. The commitment to this study will last approximately 7 weeks and include the following:
- Five (5) visits to UAB where you will fill out questionnaires, complete a DEXA scan, blood draw or Quantitative Sensory testing. These visits will last anywhere from 1-3 hrs.
- Six (6) weeks on a randomized diet where we will provide three (3) meals and two to three (2-3) snacks per day.
Participants must:
- Be currently suffering from pain related to knee osteoarthritis
- Be free from other serious health conditions (diabetes, cardiovascular disease, eating disorders, metabolic disease)
Participants will receive up to $250 for completing the study and meals will be provided. Please contact DIRECT at DIRECTPAIN1@gmail.com (205) 834-3628. Leave a short message with your name and number.
Please call 205-996-1198 if interested.